Skip to content
Biodatica
Start free

Investigator

Hongyan Guo

LOUISIANA STATE UNIV HSC SHREVEPORT · funded by NIAID, NCI, NIGMS

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.3M

Summed across those awards.

First award
Mar 1, 2021

Latest Apr 16, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    The role of ZBP1 in controlling HSV-1 pathogenesis

    $661k

    Apr 16, 2026NIAIDLOUISIANA STATE UNIV HSC SHREVEPORTNIH RePORTER · 11294827 (opens the source filing in a new tab)

  2. R21

    Boosting Oncolytic HSV Immunotherapy by Enabling Necroptosis

    $416k

    Jul 7, 2025NCILOUISIANA STATE UNIV HSC SHREVEPORTNIH RePORTER · 11212361 (opens the source filing in a new tab)

  3. P20

    Oncolytic Herpes Simplex Virus (HSV)1 as adjuvants for melanoma

    $228k

    Mar 1, 2021NIGMSLOUISIANA STATE UNIV HSC SHREVEPORTNIH RePORTER · 11128479 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources